Intravitreal Injections of Ziv-aflibercept for Macular Diseases: Diabetic Macular Edema, Wet AMD and Macular Edema Secondary to Vein Occlusons
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2016
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema; Wet age-related macular degeneration
- Focus Therapeutic Use
- 01 Oct 2016 Status changed from active, no longer recruiting to completed.
- 30 Sep 2016 Planned End Date changed from 1 Sep 2017 to 1 Sep 2016.
- 04 Jul 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Aug 2016.